SIGA Technologies
SIGA
#7361
Rank
A$0.67 B
Marketcap
A$9.38
Share price
-2.21%
Change (1 day)
0.22%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2025 (TTM): A$0.26 Billion

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is A$0.26 Billion. In 2024 the company made a revenue of A$0.22 Billion an increase over the revenue in the year 2023 that were of A$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$0.26 B20.86%
2024 A$0.22 B8.6%
2023 A$0.20 B26.16%
2022 A$0.16 B-11.71%
2021 A$0.18 B13.46%
2020 A$0.16 B325.47%
2019 A$38.19 M-94.36%
2018 A$0.67 B4209.03%
2017 A$15.71 M-24.42%
2016 A$20.79 M85.26%
2015 A$11.22 M192.53%
2014 A$3.83 M-38%
2013 A$6.18 M-28.32%
2012 A$8.63 M-30.45%
2011 A$12.41 M-34.39%
2010 A$18.91 M23.04%
2009 A$15.37 M34.49%
2008 A$11.43 M49.21%
2007 A$7.66 M-16.78%
2006 A$9.2 M-20.53%
2005 A$11.58 M387.45%
2004 A$2.37 M141.42%
2003 A$0.98 M
2001 A$2.27 M162.93%
2000 A$0.86 M33.6%
1999 A$0.64 M-20.8%
1998 A$0.81 M-40.89%
1997 A$1.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Emergent BioSolutions
EBS
A$1.13 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$3.93 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.55 B 494.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.90 B 248.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.65 B 1,301.29%๐Ÿ‡บ๐Ÿ‡ธ USA